发明名称 |
Method of making a formulation for deactivating nucleic acids |
摘要 |
The present invention relates to reagents for use in deactivating nucleic acids and methods of making and using the same. |
申请公布号 |
US8765652(B2) |
申请公布日期 |
2014.07.01 |
申请号 |
US201213531924 |
申请日期 |
2012.06.25 |
申请人 |
Gen-Probe Incorporated |
发明人 |
Nelson Norman C.;Browne Kenneth A.;Dai Lizhong;Russell James;Filipowsky Mark E.;Kaminsky Margarita B.;Kacian Daniel L. |
分类号 |
C11D3/20;C11D3/39;C09K3/00 |
主分类号 |
C11D3/20 |
代理机构 |
|
代理人 |
Devernoe David L.;Cappellari Charles B.;Grant Bruce D. |
主权项 |
1. A method of making a formulation for deactivating nucleic acids, the method comprising the steps of:
(a) separately dissolving solid forms of a corrosion-inhibiting agent and a wetting agent, the corrosion-inhibiting agent being phosphate, borate or sodium bicarbonate, and the wetting agent being a detergent or a surfactant; (b) combining together the dissolved forms of the corrosion-inhibiting agent and the wetting agent to form a first mixture; (c) combining together the first mixture with a solubilizing agent to form a second mixture, the solubilizing agent being an organic solvent or an emulsifying agent; and (d) combining together the second mixture and a deactivating agent to form the formulation, the deactivating agent being sodium hypochlorite or dichloroisocyanurate, wherein the corrosion-inhibiting agent is present in the formulation at a concentration of from about 10 mM to about 750 mM; wherein the wetting agent is present in the formulation at a concentration of from about 0.005% to about 1% (w/v); wherein the solubilizing agent is present in the formulation at a concentration of from about 0.001% to about 20% (v/v); wherein the deactivating agent is (i) present in the formulation at a concentration of from about 0.06% to about 3% (w/v) if the deactivating agent is sodium hypochlorite; wherein the deactivating agent is present in the formulation at a concentration of from about 5 mM to about 400 mM if the deactivating agent is dichloroisocyanurate; and wherein each agent of the formulation remains substantially in solution at 22° C. |
地址 |
San Diego CA US |